MA
PACB icon

MUFG Americas’s Pacific Biosciences PACB Stock Holding History

MUFG Americas’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-329
Closed -$2K – 1135
2016
Q2 		$2K Hold
329
– – ﹤0.01% 1086
2016
Q1 		$3K Buy
+329
New +$3.24K ﹤0.01% 1059
2013
Q3 		– Sell
-94,100
Closed -$237K – 1377
2013
Q2 		$237K Buy
+94,100
New +$234K ﹤0.01% 847

Other funds holding PACB

MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MUFG Americas's PACB Position: Q3 2016 in Review

MUFG Americas sold out of Pacific Biosciences (PACB) in Q3 2016, closing a stake of 329 shares — an estimated $2K sold.

MUFG Americas first reported a position in PACB in Q2 2013 and held it in 3 quarters. The position peaked at $237K in Q2 2013. 128 funds tracked by Wall St. Rank hold PACB as of Q3 2016.

  • MUFG Americas reported no remaining Pacific Biosciences position as of Q3 2016 after selling out during the quarter.
  • MUFG Americas sold 329 Pacific Biosciences shares in Q3 2016, an estimated $2K.
  • MUFG Americas first reported a position in Pacific Biosciences in Q2 2013 and held it in 3 quarters.
  • MUFG Americas's Pacific Biosciences position peaked at $237K in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2016.

Based on MUFG Americas's 13F filing for Q3 2016, filed 14 Nov 2016.